News | April 17, 2007

Siemens' 350th 3T MagnetomTrio MRI Installed

April 18, 2007 - Siemens Medical Solutions recently installed its 350th 3T MAGNETOM Trio magnetic resonance imaging (MRI) scanner at South Jersey Radiology Associates P.A. of Voorhees, NJ.

With this installation, the high-field imaging system is demonstrating that it is not only a research tool, but that it can also make an impact in clinical imaging. Additionally, the scanner is one of more than 175 worldwide 3T systems that use Siemens Medical Solutions proprietary Tim (Total imaging matrix) coil architecture, which eliminates the need for patient repositioning and manual coil changes during scans while significantly enhancing image quality.

“The Trio will allow us to advance to the next level by imaging those regions that are still problematic at 1.5T: small joints such as the wrist, forefoot and fingers,” said William F. Muhr, Jr., MD, a radiologist at South Jersey Radiology Associates P.A. “The 3T field strength moves our neuroimaging to the next level with diffusion tensor imaging and fiber tracking. The magnet will also benefit patients with renal impairments who cannot tolerate as much gadolinium contrast. The increased signal-to-noise ratio at 3T allows us to perform body imaging and MRA at reduced contrast doses. While performing these applications, the MAGNETOM Trio also excels at routine knee, hip, spine and brain imaging, allowing us to run a full patient schedule right out of the gate.”

The MAGNETOM Trio meets a wide range of imaging needs, from routine clinical use, to high-end research, combining the system’s fast gradients with one of the largest field-of-view acquisitions and the highest 3T magnet homogeneity. Siemens’ Tim technology enables the MAGNETOM Trio to address challenges encountered with other 3T systems, without compromising image quality. The high signal-to-noise ratio of the MAGNETOM Trio, in combination with Tim technology, enables reduced scan times, which consequently reduces motion artifacts, improves patient comfort and helps increase patient throughput.

“The success of MAGNETOM Trio can be attributed to its excellent performance in all radiological settings, from neurology and orthopedics to angiography and abdominal imaging,” said Nancy Gillen, vice president, MR division, Siemens Medical Solutions. “The Trio has brought advanced 3T MRI to not only leading academic medical centers but to diagnostic imaging centers and smaller hospitals as well. And our patented Tim technology continues to yield innovations as exemplified by the new generation of Siemens MRI systems.”

Related Content

Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...
VigiLanz and Cincinnati Children's Commercialize Real-Time Acute Kidney Injury Tracking
News | Contrast Media | November 30, 2018
VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that leverages Cincinnati...
Artificial Intelligence May Help Reduce Gadolinium Dose in MRI

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

News | Contrast Media | November 27, 2018
Researchers are using artificial intelligence (AI) to reduce the dose of a contrast agent that may be left behind in...
Guerbet Showcases Ongoing Collaboration With IBM Watson at RSNA 2018
News | Clinical Decision Support | November 21, 2018
Guerbet LLC USA will feature its digital solutions including its ongoing collaboration with IBM Watson Health in...
Voyageur Minerals to Begin Manufacturing Barium Contrast Products With Chief Medical Supply
News | Contrast Media | November 14, 2018
Voyageur Minerals Ltd. signed a joint venture agreement with Chief Medical Supply Ltd (CM) of Calgary, Alberta to...
Osprey Medical and GE Healthcare Launch Acute Kidney Injury Educational Program
News | Angiography | September 25, 2018
September 21, 2018 — Osprey Medical announced a collaboration with GE Healthcare on Osprey’s Be Kind to Kidneys campa
Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

News | Contrast Media | September 12, 2018
In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore co
Scientists Develop New MRI Tool for Cancer Diagnosis and Therapy

Researchers in the laboratory ‘Biomedical Nanomaterials’ of NUST MISIS. Image courtesy of PR Newsfoto/NUST MISIS.

News | Oncology Diagnostics | August 24, 2018
A European research group has developed a system that allows doctors to both improve the accuracy of diagnosing...
Iron Outperforms Gadolinium as MRI Contrast Agent

Scientists at Rice's Laboratory for Nanophotonics added iron chelates (blue) and fluorescent dye (red) to multi-layered gold nanomatryoshkas to create particles that can be used for disease therapy and diagnostics. The "theranostic" nanoparticles have a core of gold (left) that is covered by silica containing the diagnostic iron and dye, which is covered by an outer shell of gold. The particles are about 20 times smaller than a red blood cell, and by varying the thickness of the layers, LANP scientists can tune the nanomatryoshkas to convert light into cancer-killing heat. (Image courtesy of Luke Henderson/Rice University)

News | Contrast Media | August 22, 2018
Rice University nanoscientists have demonstrated a method for loading iron inside nanoparticles to create magnetic...
Guerbet Partners With Imalogix on Dose Optimization With Artificial Intelligence
News | Radiation Dose Management | August 14, 2018
August 14, 2018 — Guerbet LLC USA announced a commercial partnership with Imalogix, a provider of...